Telehealth vs. In-Clinic Medical Oversight: Which Model Fits Your Med Spa?

Two Ways to Solve the Same Problem

Every med spa needs a real medical director relationship, real exams before treatment, and protocols that hold up under scrutiny. What differs between a telehealth-oriented model and an in-clinic model is how that oversight is delivered — a physician or supervised provider evaluating patients remotely through video or asynchronous review, versus oversight built around a physical presence and in-person exams at a specific location. Neither model is inherently more compliant than the other; each has to be built correctly for the state and the services involved, and each fits a different kind of business.

Where Telehealth Fits Best

• Clinics operating across multiple states, where a single in-person medical director cannot practically be licensed and present in every location.
• Service lines like GLP-1 prescribing and hormone therapy, where an initial evaluation and ongoing monitoring do not inherently require hands-on examination.
• Businesses scaling patient volume faster than they can hire and license providers in every physical market.
• Clinics that want to separate the clinical relationship from a single physical location, so growth is not bottlenecked by finding a new in-person director every time a new location opens.

Where In-Clinic Oversight Fits Best

• Procedures that inherently require hands-on evaluation or in-person delivery, such as most injectables, laser treatments, and device-based services.
• States or specific procedure categories where the rules require an in-person exam component rather than permitting telehealth as a substitute.
• Single-location or small-footprint businesses where a locally engaged medical director is a practical, straightforward fit rather than an operational constraint.
• Clinics where the brand and patient experience are built around a physical location and hands-on care, and remote oversight would feel disconnected from that experience.

The Model Has to Match the Service, Not Just the Business

The most common mistake is picking a model at the business level — "we are a telehealth company" or "we are an in-clinic company" — and then applying it uniformly to every service, regardless of what each one actually requires. A clinic with both a GLP-1 program and an injectables menu is very likely operating under two different oversight models at once, whether or not that is how the owner thinks about it: telehealth-appropriate evaluation for the prescribing side, in-person exam and delivery for the injectable side. Trying to force one model to cover both usually means either over-building the telehealth side with unnecessary in-person requirements, or under-building the in-clinic side by treating a procedure that needs hands-on evaluation as though it could be cleared remotely.

What Stays Constant Either Way

Regardless of which model — or which mix of both — a clinic operates under, the underlying requirements do not change: a real, engaged medical director; a clearance screening appropriate to the service and compliant with the state's rules for that modality; documented standing orders; and a chart-review process that actually happens. Telehealth is not a lighter-touch version of compliance, and in-clinic is not automatically safer. Each is a different operational shape for the same set of obligations.

The Patient Experience Question

Beyond compliance and cost, the two models produce genuinely different patient experiences, and that difference matters commercially, not just operationally. A telehealth intake can be faster and more convenient for a patient renewing a GLP-1 prescription who does not want to take time off work for an in-person visit. An in-person exam, by contrast, builds a kind of trust and relationship — a patient who has met their provider face to face, in a real clinic, often has a different level of confidence in the treatment than one who has only interacted over video.

Neither experience is objectively better; they serve different patient expectations and different service categories. A clinic that defaults entirely to one model regardless of what a specific patient population actually wants is optimizing for operational simplicity at the potential cost of patient satisfaction and retention — a tradeoff worth making deliberately, not by default.

The Cost Comparison Owners Actually Care About

Telehealth-based oversight generally scales more efficiently on a per-patient basis, because a single provider group can serve patients across a wide geographic footprint without the fixed cost of a physical medical-director presence at every location. In-clinic oversight generally carries a higher fixed cost per location, but supports the kind of hands-on, high-touch service that some patient bases specifically expect and will pay a premium for.

Neither is categorically cheaper once the full picture is accounted for. A telehealth model still needs the state-specific compliance infrastructure — multiple physician licenses, state-by-state exam-modality rules — that in-clinic operators sometimes underestimate when they consider adding a telehealth service line. An in-clinic model still needs enough patient volume at each location to justify the fixed cost of real medical direction there, which is a harder threshold for a new, single-location clinic to clear than owners often expect going in.

A Practical Framework for Deciding

• List every service currently offered or planned, and for each one, determine whether the state(s) involved permit a telehealth-based exam for that specific service.
• For services that require or strongly favor in-person delivery, confirm the physical location has (or will have) adequate medical director presence to support it.
• For services that can be delivered via telehealth, confirm the plan accounts for licensing the medical director (or the supervising provider) in every state patients will actually be treated in.
• Revisit this mapping whenever a new service is added or a new state is entered — the right model for today's menu is not guaranteed to be right for next year's.

A Multi-State Example

Consider a clinic that launches a GLP-1 weight-management program with telehealth-based intake, initially in one state, and grows demand fast enough to expand into two neighboring states within a year. The telehealth model makes that expansion operationally simple in one sense — no new physical location required — but it does not remove the licensing requirement: the supervising physician or provider needs to be licensed in each new state, and each state's specific telehealth and exam-modality rules need to be confirmed before treating a single patient there, not assumed to mirror the first state's rules.

This is where a telehealth model's scalability advantage and its compliance complexity are really the same feature looked at from two angles — the ability to reach patients anywhere is exactly what requires tracking compliance requirements everywhere, rather than the one-time state-specific build an in-clinic model requires for a single fixed location.

Building the Right Mix

Most growing med spas end up running a hybrid: telehealth-appropriate oversight for prescribing-based services that can scale across states, and in-person medical oversight for procedures that require it. Getting this mix right means mapping every service on the menu against what it actually requires, rather than defaulting to whichever model the business identifies with.

MedGrid builds both sides of this — telehealth infrastructure for multi-state prescribing programs, and in-clinic medical director placement for hands-on services — so a clinic's oversight model is built around what each service actually needs, not a single company-wide assumption.